You are here: Industry Insights > revenue

News List

The top 15 pharma companies by 2018 revenue fiercepharma
April 08, 2019
The pharma industry is always in flux, but the big names always turn up near the top of yearly sales rankings.
Mylan reports lower than expected earnings pharmaphorum
February 28, 2019
Mylan has reported lower than expected full year earnings and 2019 forecasts, thanks partly to delays in its generic Advair approval and continuing problems at its US manufacturing plant.
Takeda hits FDA snag on Ninlaro, but its growth still helps drive revenue hike fiercepharma
February 02, 2019
In Takeda’s last quarterly report as a separate company from Shire, things seem to be going its way—key drugs are growing nicely, Shire integration is on track, and cash-raising sell-offs are underway, executives said.
GW launches cannabis-based epilepsy drug in US pharmaphorum
November 30, 2018
GW Pharmaceuticals is bullish about the company’s prospects following the launch of its cannabis-based medicine for a rare form of childhood epilepsy.
Natco Pharma posts over two-fold jump in Q2 PAT to ₹ 181.6 crore expressbpd
November 06, 2018
The company had posted a consolidated profit after tax of ₹ 84.4 crore in the same quarter
Pfizer Q3 results: growth in revenue and income led innovative health segment pharmaceutical-technology
October 31, 2018
Pfizer has reported a 1% or $130m growth in revenue for the third quarter (Q3) 2018 to $13.3bn, compared to Q3 2017.
NATCO Pharma posts consolidated total revenue of Rs 2078.9 cr for the year ended on March 31, 2017 financialexpress
June 01, 2017
In Q4, the company recorded a net revenue of Rs 577.2 crore, on a consolidated basis
ZEISS: Significant Growth in Revenue and Earnings en-cphi.cn
May 12, 2017
The ZEISS Group had a very successful end to the first six months of fiscal year 2016/17 (ended 31 March) and saw its revenue rise by 10 percent to EUR 2.550 billion (1st half of 2015/16: EUR 2.322 billion).
Shire's fourth-quarter sales more than double, lifted by Baxalta firstwordpharma
February 17, 2017
Shire's fourth-quarter revenue more than doubled year-over-year to $3.8 billion, in line with analyst estimates, boosted by the purchase of Baxalta, the company reported Thursday. Net income in the three-month period jumped 63 percent to $457 million.
NATCO Pharma posts consolidated revenue of Rs 685.13 cr in December quarter financialexpress
February 15, 2017
In Q3FY17, sales/ income from operations were reported at Rs 7,683 crores, registering a growth of eight over same quarter last year.

Previous page 1 2 3 4 5 Next page